1.
|
Phase: Phase III Type: Treatment Status: Active Age: 4 to 50 Sponsor: Other Protocol IDs: 108128, EudraCT number: 2008-003658-13, NCT00987636
|
|
2.
|
Phase: Phase III Type: Prevention Status: Active Age: 20 to 46 Sponsor: Other Protocol IDs: IEO S462/109, 2009-010260-41, NCT01479192
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SPOC-2011-001, NCT01535157
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000508770, U01CA062505, CCC-PHI-54, NCI-7540, 7540, NCT00387504
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 30 and under Sponsor: NCI, Other Protocol IDs: CDR0000584267, NANT-2004-03, NCT00646230
|
|
6.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: SPOC2008-01, NCT01187810
|
|
7.
|
Phase: Phase I Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: SPOC-2010-002, NCT01553071
|